Spyros Artavanis-Tsakonas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Spyros Artavanis-Tsakonas has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Anindya Sen
Biogen
8 shared publications- Guruharsha Kuthethur Gururaj
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA
8 shared publications Kazuya Hori
Department of Cell Biology, Harvard Medical School, Boston, MA, USA; University of Fukui, Fukui, Japan
7 shared publicationsMark W. Kankel
Biogen
6 shared publicationsDouglas N. Dimlich
Harvard Medical School
4 shared publicationsTakakazu Yokokura
Department of Cell Biology, Harvard Medical School
4 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (44)
Regulation of miR-219 and its target RalGPS is essential for synaptic plasticity at the Drosophila neuromuscular junction
RNA regulatory mechanisms mediate adaptive responses relying on rapid changes in gene expression. By examining microRNA (miRNA)-mediated control of structural synaptic plasticity, we find miR-219 and five other conserved miRNAs regulate activity-induced morphogenesis at Drosophila glutamatergic synapses. Among miRNA targets downregulated by acute stimulation, the Ral activating factor RalGPS is necessary for presynaptic morphogenesis and is sufficient to block plasticity. We find that RalGPS must be held within a narrow range of expression for structural remodeling to occur. Loss or excess of RalGPS both abolish activity-induced synapse growth. Without altering levels of mature miR-219, stimulation elevates miR-219 loading in Argonaute (Ago1)-containing complexes that mediate miRNA gene silencing. We also find that elevated Protein Kinase A activity suppresses miR-219 association with Ago1 and blocks activity-induced synaptic growth, suggesting that miRNA loading and unloading in neurons are both controlled by activity-dependent regulation of Ago1.
- 27 October 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (44)
Open AccessRegulation of miR-219 and its target RalGPS is essential for synaptic plasticity at the Drosophila neuromuscular junction
RNA regulatory mechanisms mediate adaptive responses relying on rapid changes in gene expression. By examining microRNA (miRNA)-mediated control of structural synaptic plasticity, we find miR-219 and five other conserved miRNAs regulate activity-induced morphogenesis at Drosophila glutamatergic synapses. Among miRNA targets downregulated by acute stimulation, the Ral activating factor RalGPS is necessary for presynaptic morphogenesis and is sufficient to block plasticity. We find that RalGPS must be held within a narrow range of expression for structural remodeling to occur. Loss or excess of RalGPS both abolish activity-induced synapse growth. Without altering levels of mature miR-219, stimulation elevates miR-219 loading in Argonaute (Ago1)-containing complexes that mediate miRNA gene silencing. We also find that elevated Protein Kinase A activity suppresses miR-219 association with Ago1 and blocks activity-induced synaptic growth, suggesting that miRNA loading and unloading in neurons are both controlled by activity-dependent regulation of Ago1.
- 28 June 2024
- Published by Elsevier in Developmental Cell
- Vol. 59 (18) , 2506-2517.e6
Next-generation Drosophila protein interactome map and its functional implications
- 28 June 2024
- Published by Elsevier in Developmental Cell
- Vol. 59 (18) , 2506-2517.e6
Next-generation Drosophila protein interactome map and its functional implications
- Open Access
- 5 June 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (24)
cAMP/PKA signaling regulates TDP-43 aggregation and mislocalization
Cytoplasmic mislocalization and aggregation of TDP-43 protein are hallmarks of amyotrophic lateral sclerosis (ALS) and are observed in the vast majority of both familial and sporadic cases. How these two interconnected processes are regulated on a molecular level, however, remains enigmatic. Genome-wide screens for modifiers of the ALS-associated genes TDP-43 and FUS have identified the phospholipase D (Pld) pathway as a key regulator of ALS-related phenotypes in the fruit fly Drosophila melanogaster [M. W. Kankel et al. , Genetics 215 , 747–766 (2020)]. Here, we report the results of our search for downstream targets of the enzymatic product of Pld, phosphatidic acid. We identify two conserved negative regulators of the cAMP/PKA signaling pathway, the phosphodiesterase dunce and the inhibitory subunit PKA-R2 , as modifiers of pathogenic phenotypes resulting from overexpression of the Drosophila TDP-43 ortholog TBPH . We show that knockdown of either of these genes results in a mitigation of both TBPH aggregation and mislocalization in larval motor neuron cell bodies, as well as an amelioration of adult-onset motor defects and shortened lifespan induced by TBPH. We determine that PKA kinase activity is downstream of both TBPH and Pld and that overexpression of the PKA target CrebA can rescue TBPH mislocalization. These findings suggest a model whereby increasing cAMP/PKA signaling can ameliorate the molecular and functional effects of pathological TDP-43.
- 5 June 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (24)
Open AccesscAMP/PKA signaling regulates TDP-43 aggregation and mislocalization
Cytoplasmic mislocalization and aggregation of TDP-43 protein are hallmarks of amyotrophic lateral sclerosis (ALS) and are observed in the vast majority of both familial and sporadic cases. How these two interconnected processes are regulated on a molecular level, however, remains enigmatic. Genome-wide screens for modifiers of the ALS-associated genes TDP-43 and FUS have identified the phospholipase D (Pld) pathway as a key regulator of ALS-related phenotypes in the fruit fly Drosophila melanogaster [M. W. Kankel et al. , Genetics 215 , 747–766 (2020)]. Here, we report the results of our search for downstream targets of the enzymatic product of Pld, phosphatidic acid. We identify two conserved negative regulators of the cAMP/PKA signaling pathway, the phosphodiesterase dunce and the inhibitory subunit PKA-R2 , as modifiers of pathogenic phenotypes resulting from overexpression of the Drosophila TDP-43 ortholog TBPH . We show that knockdown of either of these genes results in a mitigation of both TBPH aggregation and mislocalization in larval motor neuron cell bodies, as well as an amelioration of adult-onset motor defects and shortened lifespan induced by TBPH. We determine that PKA kinase activity is downstream of both TBPH and Pld and that overexpression of the PKA target CrebA can rescue TBPH mislocalization. These findings suggest a model whereby increasing cAMP/PKA signaling can ameliorate the molecular and functional effects of pathological TDP-43.
- 1 July 2020
- Published by Oxford University Press (OUP) in Genetics
- Vol. 215 (3) , 747-766
Amyotrophic Lateral Sclerosis Modifiers inDrosophilaReveal the Phospholipase D Pathway as a Potential Therapeutic Target
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a devastating neurodegenerative disorder lacking effective treatments. ALS pathology is linked to mutations in >20 different genes indicating a complex underlying genetic architecture that is effectively unknown. Here, in an attempt to identify genes and pathways for potential therapeutic intervention and explore the genetic circuitry underlying Drosophila models of ALS, we carry out two independent genome-wide screens for modifiers of degenerative phenotypes associated with the expression of transgenic constructs carrying familial ALS-causing alleles of FUS (hFUSR521C) and TDP-43 (hTDP-43M337V). We uncover a complex array of genes affecting either or both of the two strains, and investigate their activities in additional ALS models. Our studies indicate the pathway that governs phospholipase D activity as a major modifier of ALS-related phenotypes, a notion supported by data we generated in mice and others collected in humans.
- 1 July 2020
- Published by Oxford University Press (OUP) in Genetics
- Vol. 215 (3) , 747-766
Amyotrophic Lateral Sclerosis Modifiers inDrosophilaReveal the Phospholipase D Pathway as a Potential Therapeutic Target
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a devastating neurodegenerative disorder lacking effective treatments. ALS pathology is linked to mutations in >20 different genes indicating a complex underlying genetic architecture that is effectively unknown. Here, in an attempt to identify genes and pathways for potential therapeutic intervention and explore the genetic circuitry underlying Drosophila models of ALS, we carry out two independent genome-wide screens for modifiers of degenerative phenotypes associated with the expression of transgenic constructs carrying familial ALS-causing alleles of FUS (hFUSR521C) and TDP-43 (hTDP-43M337V). We uncover a complex array of genes affecting either or both of the two strains, and investigate their activities in additional ALS models. Our studies indicate the pathway that governs phospholipase D activity as a major modifier of ALS-related phenotypes, a notion supported by data we generated in mice and others collected in humans.
- Open Access
Protein domain-based structural interfaces help interpret biologically-relevant interactions in the human interaction network
A high-quality map of the human protein–protein interaction (PPI) network can help us better understand complex genotype–phenotype relationships. Each edge between two interacting proteins supported through an interface in a three-dimensional (3D) structure of a protein complex adds credibility to the biological relevance of the interaction. Such structure-supported interactions would augment an interaction map primarily built using high-throughput cell-based biophysical methods. Here, we integrate structural information with the human PPI network to build the structure-supported human interactome, a subnetwork of PPI between proteins that contain domains or regions known to form interfaces in the 3D structures of protein complexes. We expand the coverage of our structure-supported human interactome by using Pfam-based domain definitions, whereby we include homologous interactions if a human complex structure is unavailable. The structure-supported interactome predicts one-eighth of the total network PPI to interact through domain–domain interfaces. It identifies with higher resolution the interacting subunits in multi-protein complexes and enables us to characterize functional and disease-relevant neighborhoods in the network map with higher accuracy, allowing for structural insights into disease-associated genes and pathways. We expand the structural coverage beyond domain–domain interfaces by identifying the most common non-enzymatic peptide-binding domains with structural support. Adding these interactions between protein domains on one side and peptide regions on the other approximately doubles the number of structure-supported PPI. The human structure-supported interactome is a resource to prioritize investigations of smaller-scale context-specific experimental PPI neighborhoods of biological or clinical significance. Short A high-quality map of the human protein–protein interaction (PPI) network can help us better understand genotype–phenotype relationships. Each edge between two interacting proteins supported through an interface in a three-dimensional structure of a protein complex adds credibility to the biological relevance of the interaction aiding experimental prioritization. Here, we integrate structural information with the human interactome to build the structure-supported human interactome, a subnetwork of PPI between proteins that contain domains or regions known to form interfaces in the structures of protein complexes. The structure-supported interactome predicts one-eighth of the total PPI to interact through domain–domain interfaces. It identifies with higher resolution the interacting subunits in multi-protein complexes and enables us to structurally characterize functional, disease-relevant network neighborhoods. We also expand the structural coverage by identifying PPI between non-enzymatic peptide-binding domains on one side and peptide regions on the other, thereby doubling the number of structure-supported PPI.
Open AccessProtein domain-based structural interfaces help interpret biologically-relevant interactions in the human interaction network
A high-quality map of the human protein–protein interaction (PPI) network can help us better understand complex genotype–phenotype relationships. Each edge between two interacting proteins supported through an interface in a three-dimensional (3D) structure of a protein complex adds credibility to the biological relevance of the interaction. Such structure-supported interactions would augment an interaction map primarily built using high-throughput cell-based biophysical methods. Here, we integrate structural information with the human PPI network to build the structure-supported human interactome, a subnetwork of PPI between proteins that contain domains or regions known to form interfaces in the 3D structures of protein complexes. We expand the coverage of our structure-supported human interactome by using Pfam-based domain definitions, whereby we include homologous interactions if a human complex structure is unavailable. The structure-supported interactome predicts one-eighth of the total network PPI to interact through domain–domain interfaces. It identifies with higher resolution the interacting subunits in multi-protein complexes and enables us to characterize functional and disease-relevant neighborhoods in the network map with higher accuracy, allowing for structural insights into disease-associated genes and pathways. We expand the structural coverage beyond domain–domain interfaces by identifying the most common non-enzymatic peptide-binding domains with structural support. Adding these interactions between protein domains on one side and peptide regions on the other approximately doubles the number of structure-supported PPI. The human structure-supported interactome is a resource to prioritize investigations of smaller-scale context-specific experimental PPI neighborhoods of biological or clinical significance. Short A high-quality map of the human protein–protein interaction (PPI) network can help us better understand genotype–phenotype relationships. Each edge between two interacting proteins supported through an interface in a three-dimensional structure of a protein complex adds credibility to the biological relevance of the interaction aiding experimental prioritization. Here, we integrate structural information with the human interactome to build the structure-supported human interactome, a subnetwork of PPI between proteins that contain domains or regions known to form interfaces in the structures of protein complexes. The structure-supported interactome predicts one-eighth of the total PPI to interact through domain–domain interfaces. It identifies with higher resolution the interacting subunits in multi-protein complexes and enables us to structurally characterize functional, disease-relevant network neighborhoods. We also expand the structural coverage by identifying PPI between non-enzymatic peptide-binding domains on one side and peptide regions on the other, thereby doubling the number of structure-supported PPI.
- 10 September 2019
- Published by Wiley in WIREs Developmental Biology
- Vol. 9 (1) , e358
The Notch pathway in CNS homeostasis and neurodegeneration
The role of the Notch signaling pathway in neural development has been well established over many years. More recent studies, however, have demonstrated that Notch continues to be expressed and active throughout adulthood in many areas of the central nervous system. Notch signals have been implicated in adult neurogenesis, memory formation, and synaptic plasticity in the adult organism, as well as linked to acute brain trauma and chronic neurodegenerative conditions. NOTCH3 mutations are responsible for the most common form of hereditary stroke, the progressive disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Notch has also been associated with several progressive neurodegenerative diseases, including Alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis. Although numerous studies link Notch activity with CNS homeostasis and neurodegenerative diseases, the data thus far are primarily correlative, rather than functional. Nevertheless, the evidence for Notch pathway activity in specific neural cellular contexts is strong, and certainly intriguing, and points to the possibility that the pathway carries therapeutic promise.This article is categorized under: Nervous System Development > Flies Signaling Pathways > Cell Fate Signaling Nervous System Development > Vertebrates: General Principles
- 10 September 2019
- Published by Wiley in WIREs Developmental Biology
- Vol. 9 (1) , e358
The Notch pathway in CNS homeostasis and neurodegeneration
The role of the Notch signaling pathway in neural development has been well established over many years. More recent studies, however, have demonstrated that Notch continues to be expressed and active throughout adulthood in many areas of the central nervous system. Notch signals have been implicated in adult neurogenesis, memory formation, and synaptic plasticity in the adult organism, as well as linked to acute brain trauma and chronic neurodegenerative conditions. NOTCH3 mutations are responsible for the most common form of hereditary stroke, the progressive disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Notch has also been associated with several progressive neurodegenerative diseases, including Alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis. Although numerous studies link Notch activity with CNS homeostasis and neurodegenerative diseases, the data thus far are primarily correlative, rather than functional. Nevertheless, the evidence for Notch pathway activity in specific neural cellular contexts is strong, and certainly intriguing, and points to the possibility that the pathway carries therapeutic promise.This article is categorized under: Nervous System Development > Flies Signaling Pathways > Cell Fate Signaling Nervous System Development > Vertebrates: General Principles
- 19 July 2018
- Published by Springer Nature
- Vol. 1066, 125-140
The Notch Interactome: Complexity in Signaling Circuitry
The Notch pathway controls a very broad spectrum of cell fates in metazoans during development, influencing proliferation, differentiation and cell death. Given its central role in normal development and homeostasis, misregulation of Notch signals can lead to various disorders including cancer. How the Notch pathway mediates such pleiotropic and differential effects is of fundamental importance. It is becoming increasingly clear through a number of large-scale genetic and proteomic studies that Notch interacts with a staggeringly large number of other genes and pathways in a context-dependent, complex, and highly regulated network, which determines the ultimate biological outcome. How best to interpret and analyze the continuously increasing wealth of data on Notch interactors remains a challenge. Here we review the current state of genetic and proteomic data related to the Notch interactome.
- 19 July 2018
- Published by Springer Nature
- Vol. 1066, 125-140
The Notch Interactome: Complexity in Signaling Circuitry
The Notch pathway controls a very broad spectrum of cell fates in metazoans during development, influencing proliferation, differentiation and cell death. Given its central role in normal development and homeostasis, misregulation of Notch signals can lead to various disorders including cancer. How the Notch pathway mediates such pleiotropic and differential effects is of fundamental importance. It is becoming increasingly clear through a number of large-scale genetic and proteomic studies that Notch interacts with a staggeringly large number of other genes and pathways in a context-dependent, complex, and highly regulated network, which determines the ultimate biological outcome. How best to interpret and analyze the continuously increasing wealth of data on Notch interactors remains a challenge. Here we review the current state of genetic and proteomic data related to the Notch interactome.
- Open Access
- 20 August 2015
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 25 (11) , 1692-1702
Extensive cross-regulation of post-transcriptional regulatory networks in Drosophila
In eukaryotic cells, RNAs exist as ribonucleoprotein particles (RNPs). Despite the importance of these complexes in many biological processes, including splicing, polyadenylation, stability, transportation, localization, and translation, their compositions are largely unknown. We affinity-purified 20 distinct RNA-binding proteins (RBPs) from cultured Drosophila melanogaster cells under native conditions and identified both the RNA and protein compositions of these RNP complexes. We identified “high occupancy target” (HOT) RNAs that interact with the majority of the RBPs we surveyed. HOT RNAs encode components of the nonsense-mediated decay and splicing machinery, as well as RNA-binding and translation initiation proteins. The RNP complexes contain proteins and mRNAs involved in RNA binding and post-transcriptional regulation. Genes with the capacity to produce hundreds of mRNA isoforms, ultracomplex genes, interact extensively with heterogeneous nuclear ribonuclear proteins (hnRNPs). Our data are consistent with a model in which subsets of RNPs include mRNA and protein products from the same gene, indicating the widespread existence of auto-regulatory RNPs. From the simultaneous acquisition and integrative analysis of protein and RNA constituents of RNPs, we identify extensive cross-regulatory and hierarchical interactions in post-transcriptional control.
- 20 August 2015
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 25 (11) , 1692-1702
Open AccessExtensive cross-regulation of post-transcriptional regulatory networks in Drosophila
In eukaryotic cells, RNAs exist as ribonucleoprotein particles (RNPs). Despite the importance of these complexes in many biological processes, including splicing, polyadenylation, stability, transportation, localization, and translation, their compositions are largely unknown. We affinity-purified 20 distinct RNA-binding proteins (RBPs) from cultured Drosophila melanogaster cells under native conditions and identified both the RNA and protein compositions of these RNP complexes. We identified “high occupancy target” (HOT) RNAs that interact with the majority of the RBPs we surveyed. HOT RNAs encode components of the nonsense-mediated decay and splicing machinery, as well as RNA-binding and translation initiation proteins. The RNP complexes contain proteins and mRNAs involved in RNA binding and post-transcriptional regulation. Genes with the capacity to produce hundreds of mRNA isoforms, ultracomplex genes, interact extensively with heterogeneous nuclear ribonuclear proteins (hnRNPs). Our data are consistent with a model in which subsets of RNPs include mRNA and protein products from the same gene, indicating the widespread existence of auto-regulatory RNPs. From the simultaneous acquisition and integrative analysis of protein and RNA constituents of RNPs, we identify extensive cross-regulatory and hierarchical interactions in post-transcriptional control.
- Open Access
- 29 July 2015
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 4, e05996
The Notch-mediated hyperplasia circuitry in Drosophila reveals a Src-JNK signaling axis
Notch signaling controls a wide range of cell fate decisions during development and disease via synergistic interactions with other signaling pathways. Here, through a genome-wide genetic screen in Drosophila, we uncover a highly complex Notch-dependent genetic circuitry that profoundly affects proliferation and consequently hyperplasia. We report a novel synergistic relationship between Notch and either of the non-receptor tyrosine kinases Src42A and Src64B to promote hyperplasia and tissue disorganization, which results in cell cycle perturbation, JAK/STAT signal activation, and differential regulation of Notch targets. Significantly, the JNK pathway is responsible for the majority of the phenotypes and transcriptional changes downstream of Notch-Src synergy. We previously reported that Notch-Mef2 also activates JNK, indicating that there are commonalities within the Notch-dependent proliferation circuitry; however, the current data indicate that Notch-Src accesses JNK in a significantly different fashion than Notch-Mef2.
- 29 July 2015
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 4, e05996
Open AccessThe Notch-mediated hyperplasia circuitry in Drosophila reveals a Src-JNK signaling axis
Notch signaling controls a wide range of cell fate decisions during development and disease via synergistic interactions with other signaling pathways. Here, through a genome-wide genetic screen in Drosophila, we uncover a highly complex Notch-dependent genetic circuitry that profoundly affects proliferation and consequently hyperplasia. We report a novel synergistic relationship between Notch and either of the non-receptor tyrosine kinases Src42A and Src64B to promote hyperplasia and tissue disorganization, which results in cell cycle perturbation, JAK/STAT signal activation, and differential regulation of Notch targets. Significantly, the JNK pathway is responsible for the majority of the phenotypes and transcriptional changes downstream of Notch-Src synergy. We previously reported that Notch-Mef2 also activates JNK, indicating that there are commonalities within the Notch-dependent proliferation circuitry; however, the current data indicate that Notch-Src accesses JNK in a significantly different fashion than Notch-Mef2.